JACC-Cardiovascular Interventions

Papers
(The H4-Index of JACC-Cardiovascular Interventions is 54. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
3-Year Outcomes of the ULTIMATE Trial Comparing Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation180
Indigo Aspiration System for Treatment of Pulmonary Embolism173
Incidence, Predictors, and Implications of Permanent Pacemaker Requirement After Transcatheter Aortic Valve Replacement139
Transfemoral Transcatheter Tricuspid Valve Replacement With the EVOQUE System129
Coronary Cannulation After Transcatheter Aortic Valve Replacement128
ACTIVATION (PercutAneous Coronary inTervention prIor to transcatheter aortic VAlve implantaTION)126
Effect of CYP2C19 Genotype on Ischemic Outcomes During Oral P2Y12 Inhibitor Therapy112
Drug-Coated Balloon Versus Drug-Eluting Stent for Small Coronary Vessel Disease108
Distal Radial Artery Approach to Prevent Radial Artery Occlusion Trial105
Randomized Trial Comparing Standard Versus Ultrasound-Assisted Thrombolysis for Submassive Pulmonary Embolism97
Principles of Intravascular Lithotripsy for Calcific Plaque Modification97
Valve-in-Valve Transcatheter Aortic Valve Replacement Versus Redo Surgical Aortic Valve Replacement94
Intravascular Lithotripsy for Treatment of Calcified Coronary Lesions89
Randomized Comparison of Transcatheter Edge-to-Edge Repair for Degenerative Mitral Regurgitation in Prohibitive Surgical Risk Patients84
Intravascular Lithotripsy for Peripheral Artery Calcification84
Transfemoral Tricuspid Valve Replacement in Patients With Tricuspid Regurgitation83
Early Multinational Experience of Transcatheter Tricuspid Valve Replacement for Treating Severe Tricuspid Regurgitation83
Patient-Specific Implantation Technique to Obtain Neo-Commissural Alignment With Self-Expanding Transcatheter Aortic Valves81
Surgical Explantation After TAVR Failure78
Subclinical Leaflet Thrombosis After Transcatheter Aortic Valve Replacement78
Contemporary Issues in Chronic Total Occlusion Percutaneous Coronary Intervention77
Cardiopulmonary Hemodynamic Profile Predicts Mortality After Transcatheter Tricuspid Valve Repair in Chronic Heart Failure76
Short Duration of DAPT Versus De-Escalation After Percutaneous Coronary Intervention for Acute Coronary Syndromes76
Suture- or Plug-Based Large-Bore Arteriotomy Closure76
COAPT-Like Profile Predicts Long-Term Outcomes in Patients With Secondary Mitral Regurgitation Undergoing MitraClip Implantation75
Clinical Outcomes Associated With Left Atrial Appendage Occlusion Versus Direct Oral Anticoagulation in Atrial Fibrillation73
Racial, Ethnic, and Sex Disparities in Patients With STEMI and Cardiogenic Shock73
Risk of Coronary Obstruction Due to Sinus Sequestration in Redo Transcatheter Aortic Valve Replacement72
Permanent Pacemaker Reduction Using Cusp-Overlapping Projection in TAVR71
Distal or Traditional Transradial Access Site for Coronary Procedures68
3- or 1-Month DAPT in Patients at High Bleeding Risk Undergoing Everolimus-Eluting Stent Implantation68
Coronary Access After TAVR-in-TAVR as Evaluated by Multidetector Computed Tomography68
Superior Vena Cava Syndrome68
Right Ventricular Contraction Patterns in Patients Undergoing Transcatheter Tricuspid Valve Repair for Severe Tricuspid Regurgitation66
6-Month Outcomes of the TricValve System in Patients With Tricuspid Regurgitation65
Transcatheter Mitral Valve Replacement63
Prosthesis-Patient Mismatch After Aortic Valve Replacement in the PARTNER 2 Trial and Registry63
Preventing Coronary Obstruction During Transcatheter Aortic Valve Replacement63
Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients With Atrial Fibrillation After TAVR63
Alterra Adaptive Prestent and SAPIEN 3 THV for Congenital Pulmonic Valve Dysfunction62
Functional Coronary Angiography–Derived Index of Microcirculatory Resistance in Patients With ST-Segment Elevation Myocardial Infarction61
Half-Dose Direct Oral Anticoagulation Versus Standard Antithrombotic Therapy After Left Atrial Appendage Occlusion61
Distal Versus Conventional Radial Access for Coronary Angiography and Intervention60
Early Feasibility Study of Cardioband Tricuspid System for Functional Tricuspid Regurgitation60
Transcatheter Mitral Valve Repair in Cardiogenic Shock and Mitral Regurgitation59
Transcatheter Aortic Valve Replacement With Balloon-Expandable Valves59
Randomized Evaluation of TriGuard 3 Cerebral Embolic Protection After Transcatheter Aortic Valve Replacement58
Transcatheter Tricuspid Valve Replacement With the EVOQUE System58
Comparison of Doppler Flow Velocity and Thermodilution Derived Indexes of Coronary Physiology57
1-Year Outcomes of Fluoropolymer-Based Drug-Eluting Stent in Femoropopliteal Practice56
Coronary Artery Fistulas55
Predictors and Clinical Impact of Prosthesis-Patient Mismatch After Self-Expandable TAVR in Small Annuli55
1-Month Dual-Antiplatelet Therapy Followed by Aspirin Monotherapy After Polymer-Free Drug-Coated Stent Implantation55
Predicting Periprocedural Complications in Chronic Total Occlusion Percutaneous Coronary Intervention54
0.043658971786499